FDA Seizes ₹1.39 Cr Supplements with Rejected Ingredients

The Food and Drug Administration of Maharashtra recently confiscated unauthorized health supplements worth Rs 1.39 crore across seventeen premises. Consequently, this state-wide enforcement highlights the growing presence of unapproved nutraceutical ingredients in commercial dietary products. Furthermore, inspectors conducted simultaneous raids under the 'Safe Food, Safe Maharashtra' initiative to protect public health. Therefore, clinicians must remain vigilant regarding over-the-counter formulations that bypass central food safety protocols through proper pharmacological awareness and safety checks.
Crackdown on Unapproved Nutraceutical Ingredients
During the operation, regulatory authorities targeted manufacturers, distributors, and marketing agencies across multiple regions, including Pune, Nagpur, and Thane. Specifically, officials discovered formulations containing magnesium acetyl taurate and nicotinamide mononucleotide. Notably, the Food Safety and Standards Authority of India had rejected product approval applications for both compounds. In addition, manufacturers produced these supplements without obtaining valid statutory clearances. Moreover, marketers sold the items without listing the necessary food category on their licences. Consequently, a major confiscation occurred at a warehouse in Bhiwandi, where authorities seized stock worth Rs 47.65 lakh. Specifically, the flagged commercial brands included Rejuvance, Altibrain-S, Magladense, and EQOQ.
Clinical Implications and Patient Safety Concerns
Frequently, many patients consume dietary supplements for cognitive enhancement or healthy aging without consulting a physician. However, unvetted compounds such as nicotinamide mononucleotide and magnesium acetyl taurate lack established safety clearances from national regulators. Nicotinamide mononucleotide functions as an intermediate in cellular NAD+ synthesis, yet unstandardized doses carry uncertain metabolic effects. Similarly, magnesium acetyl taurate claims neuroprotective benefits without adequate regulatory substantiation. Therefore, unregulated formulations may introduce toxic impurities or interact unpredictably with prescribed medications. Consequently, medical professionals should actively question patients about their supplement regimens during routine consultations. Furthermore, when clinicians identify suspicious products, they should immediately advise discontinuation to prevent potential adverse toxicities.
Frequently Asked Questions
Q1: Why did regulatory authorities seize these specific nutraceuticals?
Regulatory authorities seized these products because manufacturers utilized magnesium acetyl taurate and nicotinamide mononucleotide. FSSAI explicitly rejected the product approval applications for both ingredients due to safety and compliance deficiencies.
Q2: What should doctors advise patients taking these supplements?
Physicians should advise patients to immediately discontinue flagged supplements such as Rejuvance, Altibrain-S, Magladense, and EQOQ. Furthermore, clinicians must report adverse events and recommend only FSSAI-approved formulations.
Q3: How can physicians verify supplement compliance in India?
Clinicians can inspect product labels for valid FSSAI license numbers and verified ingredient lists. Additionally, doctors can check official regulatory databases to confirm that dietary formulations hold valid national approvals.
For further professional upskilling, practitioners can explore relevant modules via metabolic health and clinical training programs.
References
- Maharashtra FDA seizes Rs 1.39 crore nutraceuticals containing rejectedingredients - ETHealthworld
- The Times of India. Maharashtra FDA seizes Rs 1.39 crore nutraceuticals containing rejected ingredients. November 15, 2026.
- Free Press Journal. Maharashtra FDA Seizes ₹1.90-Crore Food Stock During Statewide Crackdown. November 14, 2026.





